Company Website

Contact Information:

Lori Washington
Cell:  480-620-3649
lwashington@vcel.com

 

Virtual Exhibit Hall Home

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.

MACI Detail Aid

MACI From Biopsy to Implant

MACI Rehab Manual